Clinical Trial Update: A Phase II Study of Dexamethasone, Azacitidine, Pegaspargase and Tislelizumab Plus Radiotherapy for Patients With Stage I/II Extranodal NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

This entry describes a Phase II clinical trial evaluating dexamethasone, azacitidine, pegaspargase and tislelizumab with radiotherapy in patients with Stage I/I…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• DEXAMETHASONE (Dexamethasone)
• Pegaspargase (pegaspargase)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: NK/T Cell Lymphoma | Phase 2 | Status: RECRUITING